Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Veverimer in Adults With CKD and Metabolic Acidosis

NCT07355062 is registered in ClinicalTrials.gov with Renibus Therapeutics, Inc. as lead sponsor.

NCT NCT07355062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07355062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Veverimer in Adults With CKD and Metabolic Acidosis
Lead sponsor
Renibus Therapeutics, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
January 13, 2026
Completion date
June 30, 2027
Enrollment
150 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, metabolic acidosis